Blue Bell Consulting:Home > Design and Analysis of Clinical Trials

Design and Analysis of Clinical Trials

??FDA:??????????

Who Should Participate?

  • Managers, technical staff for QA and QC, and operators of pharmaceutical companies
  • Managers and staff in all levels of government Food and Drug Administrations
  • Administrators and researchers in medical schools, pharmacy schools, biomedical research and academic institutions
  • Administrators, doctors, and nurses of clinical sites who are conducting or about to conduct clinical trials

Objectives

  • To improve the skills of design and analysis of clinical trials in China and build a solid foundation in preparation for Chinese pharmaceutical products to enter the U.S. market
  • To improve the acceptability of Chinese clinical trial sites in international regulatory bodies and to attract international clinical trial business to China

Register Now